Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- The Orange County Register, Calif., Business Briefs Column.(Knight Ridder/Tribune Business News)
- Jul. 7--ICN PURCHASES SWISS DRUG MAKER SOLCO: ICN Pharmaceuticals Inc., the Costa Mesa-based drug maker, said Wednesday that it purchased a small Swiss drug maker, Solco Basel AG, as part of its ongoing effort to broaden its skin-care product line an Jul. 7--ICN PURCHASES SWISS DRUG...
- Research articles 2000-07-07
- FDA eases approval rules for drug makers.(Industry Newsline)
- Under new guidelines designed to prevent supply disruptions, drug makers will not need regulatory approval for every change in their manufacturing processes, the U.S. Food and Drug Administration said last month. In a report detailing its two-year ef Under new guidelines designed to prevent supply disruptions,...
- Research articles 2004-10-01
- Dr Reddy's loses potency as Eli Lilly wins Zyprexa case.
- Apr. 16--MUMBAI, India -- The Dr Reddy's Laboratories scrip crashed on Friday as the loss of a key US court case against drug giant Eli Lilly added to the troubled Hyderabad-based drug maker's problems and underscored, once again, the difficulties of Apr. 16--MUMBAI, India -- The...
- Research articles 2005-04-16
- McKesson Corporation Completes Acquisition of McQueary Bros. Drug Company
- SAN FRANCISCO -- McKesson Corporation (NYSE:MCK) today announced that it has completed its acquisition of McQueary Bros. Drug Company, a Springfield, Missouri-based regional distributor of pharmaceutical, health, and beauty products to more than 400 independent pharmacies in Missouri, Arkansas, Illinois, Kansas, Oklahoma, Nebraska, and Iowa. As a result of this...
- Research articles 2008-05-21
- Gaithersburg-based drug maker MedImmune loses one patent suit in
- Gaithersburg-based drug maker MedImmune Inc. said a U.S. court rejected a motion by Indian drugmaker Sun Pharmaceutical Industries Ltd. to drop an infringement suit on one patent, but ruled another was not infringed by Sun. The U.S. District Court for the District of Maryland denied a summary judgment requested by...
- Research articles 2007-01-11
- Frist Inoculates Drug Makers for Any Vaccine Liability After Industry Won Him Senate & He Himself Said Anthrax Was Problematic
- SANTA MONICA, Calif., Nov. 16 /U.S. Newswire/ -- Senate Majority Leader Bill Frist is seeking a last-minute amendment to an appropriations bill that would remove legal liability from a drug company if the Bush Administration declares its vaccines are needSANTA MONICA, Calif., Nov. 16 /U.S. Newswire/ -- Senate Majority Leader...
- Research articles 2005-11-16
- Bitter pill for drug companies.(Viewpoint)(U.S. pharmaceutical industry battles cheap imports)
- Mayor Michael Bloomberg says New York City could save millions by importing brand-name drugs from Canada, where government-imposed controls keep prices low. He may be right in the short term. But if he and others are successful, the nation's pharmace Mayor Michael Bloomberg says New York...
- Research articles 2003-11-03
- The H. Lee Moffitt Cancer Center and Research Institute and drug maker Merck are launching a for-profit research group called M2GEN that will focus on creating individually tailored cancer treatments.(TAMPA)
- The H. Lee Moffitt Cancer Center and Research Institute and drug maker Merck are launching a for-profit research group called M2GEN that ... The H. Lee Moffitt Cancer Center and Research Institute and drug maker Merck are launching a for-profit research group called M2GEN that will...
- Research articles 2007-02-01
- Alliance for Justice and Other Consumer Groups Ask Congress to Protect People, Not Drug Companies
- WASHINGTON, Dec. 7 /U.S. Newswire/ -- Alliance for Justice, together with five other national consumer groups, sent a letter to Congressional leaders today expressing concern about a proposal that provides drug companies liability protection for vaccines WASHINGTON, Dec. 7 /U.S. Newswire/ -- Alliance for Justice, together with five other national...
- Research articles 2005-12-07
- Drug Maker Eli Lilly Reports 16 Percent Increase in Quarterly Profit.(Knight Ridder/Tribune Business News)
- Jul. 21--Prozac's sales plunged, but the drugs Eli Lilly and Co. is less famous for boosted the drugmaker's revenue and profit by double-digit levels in the second quarter. Jul. 21--Prozac's sales plunged, but the drugs Eli Lilly and Co. is less famous for boosted...
- Research articles 2000-07-21
- Pharma Industry Concerned Over Drug Competition Bill.(Brief Article)
- THE PHARMACEUTICAL industry is concerned over a Senate committee's approval of legislation that would require brand-name drug companies to report to federal officials any time they pay a generic manufacturer to delay market introduction of a lower- THE PHARMACEUTICAL industry is concerned over a...
- Research articles 2001-10-29
- PFIZER TO CUT DOWN 2,200 JOB
- AsiaInfo Services 12-04-2006 Pfizer to Cut down 2,200 Job SHANGHAI, Dec 04, 2006 SinoCast via COMTEX -- Pfizer Inc., the world's largest drugmaker, said on November 29 that it will axe 2,200 employees in its sales department in US, accounting ...
- Research articles 2006-12-04
- Administration urged to restore use tests on pediatric drugs. (Markets).(Brief Article)
- A BIPARTISAN group of senators has asked the Bush administration to restore a federal regulation requires drug firms to test their products for use by children. In a letter to Health and Human Services Secretary Tommy Thompson, the lawmakers ...
- Research articles 2002-04-22
- Leahy Plans to Seek Compromise For Drug Monopoly Legislation.(Senate Judiciary Committee )(Government Activity)(Brief Article)
- THE INCOMING chairman of the Senate Judiciary Committee intends to pursue legislation to prevent brand-name drug companies from delaying generic competition. But Sen. Patrick Leahy (D-Vt.), in line to replace current chairman Orrin Hatch (R-U THE INCOMING chairman...
- Research articles 2001-06-04
- The Insider.(AARP planning to push for laws on selling prescription data to drug companies)(Business and Labor Coalition of New York may be more inclined towards businesses)(Rita Schwartz surfaces as potential candidate for commissioner of New York Depart
- Byline: Erik Engquist and Anne Michaud Seniors take on pharmacy chains Senior lobby AARP plans a major push in Albany for legislation to stop doctors' prescription data from being compiled and sold to drug companies. AARP's state legislative dir Byline: Erik...
- Research articles 2007-03-26
- What else can be done?
- Byline: Daniel Rome Levine A framework for generic biopharmaceutical drugs is not the only area Congress should act on to help protect employers, health insurers and consumers from rising drug costs: Biodefense legislation The Senate is consider Byline: Daniel Rome Levine...
- Research articles 2006-01-02
- FTC to Investigate Possible Pharma Collusion.(payoffs for delays of generic drug introductions)(Brief Article)
- Agreements among brand and generic drug makers could be hurting consumers. THE FEDERAL Trade Commission will investigate whether agreements between brand-name and generic drug makers have cost consumers millions of dollars per year by denying Agreements among brand...
- Research articles 2000-10-16
- Data dilemma.(American Medical Group Association, Aventis partnership)(Brief Article)
- When it comes to privacy and medical data, the issues seldom are black and white. That makes a data-gathering venture between the American Medical Group Association and pharmaceutical giant Aventis a cause for both interest and concern. On the sur When it comes...
- Research articles 2001-03-12
- Orange, Calif., Drug Distributor Takes Write-off on Underperforming Units.(Knight Ridder/Tribune Business News)
- Jul. 27--ORANGE, Calif.--Drug distributor Bergen Brunswig Corp. stepped out from under the financial shadow of two poorly performing divisions Tuesday by taking a $251 million write-off on the units, which it has announced it will sell. Jul. 27--ORANGE, Calif.--Drug distributor Bergen Brunswig Corp. ...
- Research articles 2000-07-26
- Insulin by Danish Drugmaker to Be Sold under Wal-Mart Brand Name.(Knight Ridder/Tribune Business News)
- Sep. 2--A Danish drugmaker will try to chip away at Eli Lilly and Co.'s commanding U.S. market share for insulin by selling its competing product cheaper under a Wal-Mart brand name. Sep. 2--A Danish drugmaker will try to chip away at Eli Lilly and ...
- Research articles 2000-09-05
- << Previous
- page 1 of 4
- Next >>
Refining Tags
- Jim Edwards (23 results)
- Pharmaceutical Company (20 results)
- FDA (12 results)
- Marketing (11 results)
- Government (10 results)
- Pfizer Inc. (8 results)
- Federal Government (7 results)
- Sales (7 results)
- David P. Hamilton (7 results)
- Enterprise Software (6 results)
- Software (6 results)
- Human Resources (6 results)
- Healthcare (6 results)
- Marketing Research (5 results)
- Advertisement (5 results)
- U.S. Senate (5 results)
- Sales Force Management (5 results)
- Vertical Industries (5 results)
- Sales Strategy (5 results)
- Management (4 results)
- Vaccine (4 results)
- Benefits (4 results)
- Finance (4 results)
- Health Care (4 results)
- Business Operations (4 results)
- Manufacturing (3 results)
- Internet (3 results)
- Physician (3 results)
- Advertising & Promotion (3 results)
- Patent (3 results)
- FTC (3 results)
- Personal Technology (3 results)
- Drug (3 results)
- Patient (3 results)
- U.S. Congress (3 results)
- Sales Force (3 results)

